Literature DB >> 20868231

Mechanisms and cell signaling in alcoholic liver disease.

Juliane I Beier1, Craig J McClain.   

Abstract

Alcoholic liver disease (ALD) remains a major cause of morbidity and mortality worldwide. For example, the Veterans Administration Cooperative Studies reported that patients with cirrhosis and superimposed alcoholic hepatitis had a 4-year mortality of >60%. The poor prognosis of ALD implies that preventing disease progression would be more effective than treating end-stage liver disease. An obvious avenue of prevention would be to remove the damaging agent; however, the infamously high rate of recidivism in alcoholics makes maintaining abstinence a difficult treatment goal to prevent ALD. Indeed, although the progression of ALD is well-characterized, there is no universally accepted therapy available to halt or reverse this process in humans. With better understanding of the mechanism(s) and risk factors that mediate the initiation and progression of ALD, rational targeted therapy can be developed to treat or prevent ALD. The purpose of this review is to summarize the established and proposed mechanisms by which chronic alcohol abuse damages the liver and to highlight key signaling events known or hypothesized to mediate these effects.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20868231      PMCID: PMC3755482          DOI: 10.1515/BC.2010.137

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  158 in total

1.  Oxygen dependence of glutathione synthesis in hepatocytes.

Authors:  X Shan; T Y Aw; R Shapira; D P Jones
Journal:  Toxicol Appl Pharmacol       Date:  1989-11       Impact factor: 4.219

2.  The coagulation cascade in cirrhosis.

Authors:  Dougald M Monroe; Maureane Hoffman
Journal:  Clin Liver Dis       Date:  2009-02       Impact factor: 6.126

3.  N-acetylcysteine induces cell cycle arrest in hepatic stellate cells through its reducing activity.

Authors:  K Y Kim; T Rhim; I Choi; S S Kim
Journal:  J Biol Chem       Date:  2001-08-16       Impact factor: 5.157

Review 4.  Ethanol metabolism, cirrhosis and alcoholism.

Authors:  C S Lieber
Journal:  Clin Chim Acta       Date:  1997-01-03       Impact factor: 3.786

Review 5.  PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure.

Authors:  Carles Cantó; Johan Auwerx
Journal:  Curr Opin Lipidol       Date:  2009-04       Impact factor: 4.776

6.  Acute alcohol produces hypoxia directly in rat liver tissue in vivo: role of Kupffer cells.

Authors:  G E Arteel; J A Raleigh; B U Bradford; R G Thurman
Journal:  Am J Physiol       Date:  1996-09

Review 7.  Signalling pathways in alcohol-induced liver inflammation.

Authors:  Pranoti Mandrekar; Gyongyi Szabo
Journal:  J Hepatol       Date:  2009-03-28       Impact factor: 25.083

8.  Thrombin mediates mitogenesis and survival of human endothelial cells through distinct mechanisms.

Authors:  Panagiota Zania; Matthew Papaconstantinou; Christodoulos S Flordellis; Michael E Maragoudakis; Nikos E Tsopanoglou
Journal:  Am J Physiol Cell Physiol       Date:  2008-03-26       Impact factor: 4.249

9.  Endogenous nitric oxide attenuates ethanol-induced perturbation of hepatic circulation in the isolated perfused rat liver.

Authors:  M Oshita; Y Takei; S Kawano; T Hijioka; E Masuda; M Goto; Y Nishimura; H Nagai; S Iio; S Tsuji
Journal:  Hepatology       Date:  1994-10       Impact factor: 17.425

10.  Chronic enteral ethanol treatment causes hypoxia in rat liver tissue in vivo.

Authors:  G E Arteel; Y Iimuro; M Yin; J A Raleigh; R G Thurman
Journal:  Hepatology       Date:  1997-04       Impact factor: 17.425

View more
  66 in total

Review 1.  Zinc and liver disease.

Authors:  Mohammad K Mohammad; Mohammad K Mohommad; Zhanxiang Zhou; Matthew Cave; Ashutosh Barve; Craig J McClain
Journal:  Nutr Clin Pract       Date:  2012-02       Impact factor: 3.080

Review 2.  Binge drinking: Burden of liver disease and beyond.

Authors:  Susana Llerena; María Teresa Arias-Loste; Angela Puente; Joaquín Cabezas; Javier Crespo; Emilio Fábrega
Journal:  World J Hepatol       Date:  2015-11-28

Review 3.  NKT cells in liver diseases.

Authors:  Shasha Zhu; Huimin Zhang; Li Bai
Journal:  Front Med       Date:  2018-04-06       Impact factor: 4.592

4.  Knockout of microRNA-21 attenuates alcoholic hepatitis through the VHL/NF-κB signaling pathway in hepatic stellate cells.

Authors:  Nan Wu; Kelly McDaniel; Tianhao Zhou; Sugeily Ramos-Lorenzo; Chaodong Wu; Li Huang; Demeng Chen; Tami Annable; Heather Francis; Shannon Glaser; Gianfranco Alpini; Fanyin Meng
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-05-31       Impact factor: 4.052

5.  Brown fat activation mitigates alcohol-induced liver steatosis and injury in mice.

Authors:  Hong Shen; Lin Jiang; Jiandie D Lin; M Bishr Omary; Liangyou Rui
Journal:  J Clin Invest       Date:  2019-03-19       Impact factor: 14.808

Review 6.  Relationships among alcoholic liver disease, antioxidants, and antioxidant enzymes.

Authors:  Kyu-Ho Han; Naoto Hashimoto; Michihiro Fukushima
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

7.  Alcohol steatosis and cytotoxicity: the role of cytochrome P4502E1 and autophagy.

Authors:  Defeng Wu; Xiaodong Wang; Richard Zhou; Lili Yang; Arthur I Cederbaum
Journal:  Free Radic Biol Med       Date:  2012-07-20       Impact factor: 7.376

8.  Chronic alcohol ingestion and predisposition to lung "cirrhosis".

Authors:  Jesse Roman
Journal:  Alcohol Clin Exp Res       Date:  2014-01-15       Impact factor: 3.455

Review 9.  Dysregulation of redox pathways in liver fibrosis.

Authors:  Natalie J Torok
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-08-25       Impact factor: 4.052

10.   Fibrin-mediated integrin signaling plays a critical role in hepatic regeneration after partial hepatectomy in mice.

Authors:  Juliane I Beier; Luping Guo; Jeffrey D Ritzenthaler; Swati Joshi-Barve; Jesse Roman; Gavin E Arteel
Journal:  Ann Hepatol       Date:  2016 Sep-Oct       Impact factor: 2.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.